241 related articles for article (PubMed ID: 19463800)
1. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer.
Choi EH; Kim JT; Kim JH; Kim SY; Song EY; Kim JW; Kim SY; Yeom YI; Kim IH; Lee HG
Clin Chim Acta; 2009 Aug; 406(1-2):45-51. PubMed ID: 19463800
[TBL] [Abstract][Full Text] [Related]
2. Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity.
Kim JT; Lee SJ; Kang MA; Park JE; Kim BY; Yoon DY; Yang Y; Lee CH; Yeom YI; Choe YK; Lee HG
Cell Death Dis; 2013 Dec; 4(12):e974. PubMed ID: 24357805
[TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of S100A6 in human gastric cancer.
Yang YQ; Zhang LJ; Dong H; Jiang CL; Zhu ZG; Wu JX; Wu YL; Han JS; Xiao HS; Gao HJ; Zhang QH
J Dig Dis; 2007 Nov; 8(4):186-93. PubMed ID: 17970874
[TBL] [Abstract][Full Text] [Related]
4. Let‑7d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.
Jiang J; Liu HL; Tao L; Lin XY; Yang YD; Tan SW; Wu B
Int J Oncol; 2018 Aug; 53(2):781-790. PubMed ID: 29845224
[TBL] [Abstract][Full Text] [Related]
5. Identification of cystatin SN as a novel biomarker for pancreatic cancer.
Jiang J; Liu HL; Liu ZH; Tan SW; Wu B
Tumour Biol; 2015 May; 36(5):3903-10. PubMed ID: 25577248
[TBL] [Abstract][Full Text] [Related]
6. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.
Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG
Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829
[TBL] [Abstract][Full Text] [Related]
7. Expression of type 2 cystatin genes CST1-CST5 in adult human tissues and the developing submandibular gland.
Dickinson DP; Thiesse M; Hicks MJ
DNA Cell Biol; 2002 Jan; 21(1):47-65. PubMed ID: 11879580
[TBL] [Abstract][Full Text] [Related]
8. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
9. A new multi-domain member of the cystatin superfamily expressed by Fasciola hepatica.
Khaznadji E; Collins P; Dalton JP; Bigot Y; Moiré N
Int J Parasitol; 2005 Sep; 35(10):1115-25. PubMed ID: 16115636
[TBL] [Abstract][Full Text] [Related]
10. Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation.
Oh SS; Park S; Lee KW; Madhi H; Park SG; Lee HG; Cho YY; Yoo J; Dong Kim K
Cell Death Dis; 2017 Apr; 8(4):e2729. PubMed ID: 28383558
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin.
Saleh Y; Siewiński M; Kielan W; Ziółkowski P; Gryboś M; Rybka J
J Exp Ther Oncol; 2003; 3(6):319-24. PubMed ID: 14678520
[TBL] [Abstract][Full Text] [Related]
12. Novel expression of CST1 as candidate senescence marker.
Keppler D; Zhang J; Bihani T; Lin AW
J Gerontol A Biol Sci Med Sci; 2011 Jul; 66(7):723-31. PubMed ID: 21636832
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer.
Bell-McGuinn KM; Garfall AL; Bogyo M; Hanahan D; Joyce JA
Cancer Res; 2007 Aug; 67(15):7378-85. PubMed ID: 17671208
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth.
Hosokawa M; Kashiwaya K; Eguchi H; Ohigashi H; Ishikawa O; Furihata M; Shinomura Y; Imai K; Nakamura Y; Nakagawa H
Cancer Sci; 2008 Aug; 99(8):1626-32. PubMed ID: 18754876
[TBL] [Abstract][Full Text] [Related]
15. Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma.
Yang J; Luo G; Li C; Zhao Z; Ju S; Li Q; Chen Z; Ding C; Tong X; Zhao J
BMC Cancer; 2022 May; 22(1):589. PubMed ID: 35637432
[TBL] [Abstract][Full Text] [Related]
16. Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system.
Tseng CC; Tseng CP; Levine MJ; Bobek LA
Arch Biochem Biophys; 2000 Aug; 380(1):133-40. PubMed ID: 10900142
[TBL] [Abstract][Full Text] [Related]
17. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.
Dai DN; Li Y; Chen B; Du Y; Li SB; Lu SX; Zhao ZP; Zhou AJ; Xue N; Xia TL; Zeng MS; Zhong Q; Wei WD
J Mol Med (Berl); 2017 Aug; 95(8):873-886. PubMed ID: 28523467
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of the sugarcane cystatin CaneCPI-4 on cathepsins B and L and human breast cancer cell invasion.
Gianotti A; Sommer CA; Carmona AK; Henrique-Silva F
Biol Chem; 2008 Apr; 389(4):447-53. PubMed ID: 18208350
[TBL] [Abstract][Full Text] [Related]
20. Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis.
Nocera AL; Mueller SK; Workman AD; Wu D; McDonnell K; Sadow PM; Amiji MM; Bleier BS
J Allergy Clin Immunol; 2022 Oct; 150(4):872-881. PubMed ID: 35660375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
